Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on LinkedIn:
“2026 has been a record year for FDA approvals in breast cancer!
Miami Breast 2027 is an unparalleled opportunity to
- put these advances into clinical context
- discuss emerging controversies
- explore their implications for patient care.
Delighted to serve on the Steering Committee of this fantastic meeting, bringing together leading experts in breast oncology for engaging discussions.
And what better setting than the beautiful Fontainebleau Miami Beach.
- March 4-7, 2027!
Registration is FREE using code TARANTINO.
Looking forward to seeing many friends and colleagues in Miami!”

You may also be interested in:
Paolo Tarantino: Celebrating 20 Years of the Translational Breast Cancer Research Consortium
Paolo Tarantino: Individualizing T-DXd Treatment Duration in HER2-Positive Breast Cancer
Paolo Tarantino: ‘Right-Sizing’ Strategies for HER2-Positive Breast Cancer